Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03089970 · ClinicalTrials.gov registry record
Using Breath Metabolites to Determine Specific Virus Infection in Asthmatic Patients
A clinical trial, sponsored by University of California, Davis.
- Completed
- Registry status
- 19
- Enrollment target
NCT03089970 is a clinical trial that has completed, run by University of California, Davis. The registered enrollment target is 19 participants.
The verdict
NCT03089970 has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- 19 participants
- Enrollment target
Study Summary
Respiratory virus infections cause a majority of asthma exacerbations in the fall to spring months. Current diagnostic platforms for respiratory viruses have limitations including cost, availability, and invasiveness. The use of noninvasive breath collection to analyze breath metabolites may be used to differentiate virus-infected asthmatics from other causes of acute asthma exacerbations.
Interventions
- DIAGNOSTIC_TEST Exhaled breath condensate collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2017-02-01 |
| Est. Completion | 2020-09-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03089970
The ClinicalTrials.gov registry entry for NCT03089970 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Exhaled breath condensate collection is the first listed.
NCT03089970 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03089970 about?
NCT03089970 is a clinical study titled "Using Breath Metabolites to Determine Specific Virus Infection in Asthmatic Patients". Respiratory virus infections cause a majority of asthma exacerbations in the fall to spring months. Current diagnostic platforms for respiratory viruses have limitations including cost, availability, and invasiveness. The use of noninvasive breath collection to analyze breath metabolites may be used...
What is the current status of trial NCT03089970?
This trial is currently completed. The enrollment target is 19 participants. The study started on 2017-02-01. Estimated completion is 2020-09-01.
What interventions are being tested in trial NCT03089970?
The interventions under investigation include: Exhaled breath condensate collection (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03089970?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.